The global Myotonic Dystrophy Treatment Market size is expected to be valued at US$ 874.39 Million in 2023. With the strategic initiative adopted by market players and strict regulatory framework, the overall demand for Myotonic Dystrophy Treatment is projected to grow at a CAGR of 12.3% between 2023 and 2033, totaling around US$ 2,789.35 Million …
Category Archives: Healthcare Trends
Combined Sales of Hyaluronic Acid Personal Care Products is likely to cross US$ 7.36 billion by 2033. Increasing Consumer Consciousness of Skin Care Impacts the Demand for Hyaluronic Acid Personal Care Products.
In 2033, the global market for hyaluronic acid personal care products is expected to reach US$ 7.36 billion, up from US$ 3.26 billion in 2023. This market is expected to register an 8.5% CAGR over the next few years, due to growing concerns about the appearance of aging populations. It is easy to purchase these …
Combined Sales of Infertility Drugs Market Will Cross US$ 6,814.68 million by 2033; Ovulation Disorder is Leading to a Rise in Demand for Infertility Drugs.
The global infertility drugs market size was valued at US$ 3,699.8 million in the year 2023 and is projected to grow to US$ 6,814.68 million by 2033. This market is expected to register a CAGR of 6.3% during the analysis period. Due to the increase in infertility, a rise in the demand for infertility drugs …
Pleural Disease Therapeutics Market to reach US$ 9.4 billion in 2033, Thoracentesis based Treatment to account for 34% Revenue: FMI
A recently published study by Future Market Insights, the global pleural disease therapeutics market is expected to accumulate a valuation of US$ 9.4 billion by 2033, registering a CAGR of 6.5% across the forthcoming decade. Increasing prevalence of congestive heart failure, and other heart conditions, lung conditions, pneumonia, cancer and tuberculosis is estimated to propel …
Global Optic Atrophy Management Market to surpass US$ 15 billion by 2033, growing at a 4.9% CAGR: FMI Study
According to Future Market Insights, the optic atrophy management market is slated to experience a CAGR of 4.9% from 2023 to 2033, anticipated to reach a valuation of US$ 15.63 billion. An existing medical study in gene replacement therapy found a satisfactory safety record but poor medicinal result durability. The findings of the study are …
Medical Disposables Market to be worth US$ 326 Billion by 2033, Reveals Future Market Insights
The Medical Disposables Market revenues were estimated at US$ 153.5 Billion in 2022 and is anticipated to grow at a CAGR of 7.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 326 Billion. Bandages and Wound Dressings commanded the largest …
Next Generation Immunotherapies Market to reach US$ 268.84 billion by 2033, Monoclonal Antibodies were Primary Drug Class: FMI Report
The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …
Global Monkeypox Treatment Market to reach US$ 249 million by 2033, Tecovirimat to account for 61% of all Therapeutic Approaches: FMI
A recent Future Market Insights report on the monkeypox treatment market forecasts that demand is expected to rise at a CAGR of 10.25% from 2023 to 2033. As per the findings, a valuation of US$ 249 million is expected for the market by the end of the said forecast period. Rising products approvals in treatment …
Global Opioid Use Disorder Treatment Market to reach US$ 8.4 billion by 2033, Buprenorphine to account for 81.4% of all Treatments: FMI Study
The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating awareness among people …
Nasal Polyposis Treatment Market to reach US$ 8.8 billion by 2033, Corticosteroids to Constitute 55% of all Treatments: FMI Report
in value terms by 2023-end and is projected to rise at a CAGR of 6.7% until 2033, according to a recently published report by Future Market Insights. By the end of the said forecast period, a valuation of US$ 8.8 billion is expected for the market. A growing geriatric population suffering from chronic rhinosinusitis, with …